Position in LLY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,291,236
+$757,270 QoQ
Shares Held
2,744
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#2,042
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Management Associates, Inc. holds $14,108,701 across 10 Drug Manufacturers - General names. LLY ranks #2 (23.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,266 | $3,369,166 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,744 | $3,291,236 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,581 | $2,002,158 | |
| 4 | ABBV |
AbbVie Inc.
|
6,759 | $1,700,834 | |
| 5 | PFE |
Pfizer Inc
|
63,133 | $1,520,242 | |
| 6 | AMGN |
Amgen Inc
|
3,099 | $1,122,209 | |
| 7 | AZN |
Astrazeneca PLC
|
1,780 | $337,523 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,535 | $320,271 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,291,236 | 2,744 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,533,966 | 2,755 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,968,793 | 3,693 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,813,944 | 3,688 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $2,896,733 | 3,716 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,049,259 | 3,692 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $2,847,908 | 3,689 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $3,286,837 | 3,710 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $3,366,202 | 3,718 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $2,892,455 | 3,718 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $2,278,051 | 3,908 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $2,054,522 | 3,825 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $1,784,937 | 3,806 | Shares | Sole | 2025-05-28 | |
| 2023-03-31 | $1,574,237 | 4,584 | Shares | Sole | 2025-05-28 | |
| 2022-12-31 | $1,700,058 | 4,647 | Shares | Sole | 2025-05-28 | |
| 2022-09-30 | $1,662,989 | 5,143 | Shares | Sole | 2025-05-28 | |
| 2022-06-30 | $1,688,914 | 5,209 | Shares | Sole | 2025-05-28 | |
| 2022-03-31 | $1,521,197 | 5,312 | Shares | Sole | 2025-05-28 | |
| 2021-12-31 | $1,467,280 | 5,312 | Shares | Sole | 2025-05-28 | |
| 2021-09-30 | $1,254,601 | 5,430 | Shares | Sole | 2025-05-28 | |
| 2021-06-30 | $1,257,081 | 5,477 | Shares | Sole | 2025-05-28 | |
| 2021-03-31 | $831,162 | 4,449 | Shares | Sole | 2025-05-28 | |
| 2020-12-31 | $626,396 | 3,710 | Shares | Sole | 2025-05-28 | |
| 2020-09-30 | $548,562 | 3,706 | Shares | Sole | 2025-05-28 | |
| 2020-06-30 | $607,794 | 3,702 | Shares | Sole | 2025-05-28 | |
| 2020-03-31 | $402,149 | 2,899 | Shares | Sole | 2025-05-28 | |
| No filing history on record for this holder in this stock. | ||||||